M

A

MONFORTE , Antonella D'arminio

Last name: MONFORTE

First name: Antonella D'arminio

2016 (v1)

Publication

Metadata-only

Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial

Galli, Laura Spagnuolo, Vincenzo Bigoloni, Alba

Objectives: To report the 96 week results on efficacy, safety and bone mineral density (BMD) in subjects with HIV-1 that were virologically suppressed and treated with atazanavir/ritonavir monotherapy versus atazanavir/ ritonavir triple therapy. Methods: MODAt is a prospective, multicentre, open-label, non-inferiority, randomized, 96 week trial...

Uploaded on: May 13, 2023
2017 (v1)

Publication

Metadata-only

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

Cento, Valeria Nguyen, Thi Huyen Tram Di Carlo, Domenico

Background: Intracellular HCV-RNA reduction is a proposed mechanism of action of direct-acting antivirals (DAAs), alternative to hepatocytes elimination by pegylated-interferon plus ribavirin (PR). We modeled ALT and HCV-RNA kinetics in cirrhotic patients treated with currently-used all-DAA combinations to evaluate their mode of action and...

Uploaded on: April 14, 2023